AAAAAA
Results: 1-25/43
Authors:
Ruiz, L
Negredo, E
Domingo, P
Paredes, R
Francia, E
Balague, M
Gel, S
Bonjoch, A
Fumaz, CR
Johnston, S
Romeu, J
Lange, J
Clotet, B
Citation: L. Ruiz et al., Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy, J ACQ IMM D, 27(3), 2001, pp. 229-236
Authors:
Escribano, P
Beltran, H
Cordoncillo, E
Garcia-Belmonte, G
Ruiz, L
Gonzalez-Calbet, JM
West, AR
Citation: P. Escribano et al., Ferroelectric behavior of Pb(Mg1/3Nb2/3)O-3 (PMN) obtained by the sol-gel method, CHEM MATER, 13(2), 2001, pp. 415-419
Authors:
Dronda, F
Casado, JL
Moreno, S
Hertogs, K
Garcia-Arata, I
Antela, A
Perez-Elias, MJ
Ruiz, L
Larder, B
Citation: F. Dronda et al., Phenotypic cross-resistance to nelfinavir: The role of prior antiretroviral therapy and the number of mutations in the protease gene, AIDS RES H, 17(3), 2001, pp. 211-215
Authors:
Beaujouan, V
Durand, P
Ruiz, L
Citation: V. Beaujouan et al., Modelling the effect of the spatial distribution of agricultural practiceson nitrogen fluxes in rural catchments, ECOL MODEL, 137(1), 2001, pp. 93-105
Authors:
Ruiz, L
Carcelain, G
Martinez-Picado, J
Frost, S
Marfil, S
Paredes, R
Romeu, J
Ferrer, E
Morales-Lopetegi, K
Autran, B
Clotet, B
Citation: L. Ruiz et al., HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection, AIDS, 15(9), 2001, pp. F19-F27
Authors:
Gallego, O
Ruiz, L
Vallejo, A
Ferrer, E
Rubio, A
Clotet, B
Leal, M
Soriano, V
Citation: O. Gallego et al., Changes in the rate of genotypic resistance to antiretroviral drugs in Spain, AIDS, 15(14), 2001, pp. 1894-1896
Authors:
Tuldra, A
Fumaz, CR
Ferrer, MJ
Paredes, R
Romeu, J
Ruiz, L
Bayes, R
Clotet, B
Citation: A. Tuldra et al., Psychological impact of structured treatment interruptions in patients with prolonged undetectable HIV-1 viral loads, AIDS, 15(14), 2001, pp. 1904-1906
Authors:
Perez-Olmeda, M
Del Romero, J
Rubio, A
Ruiz, L
Rodriguez, C
Leal, M
Clotet, B
Soriano, V
Citation: M. Perez-olmeda et al., Primary HIV-1 drug resistance in spain before and after the introduction of protease inhibitors, J MED VIROL, 63(2), 2001, pp. 85-87
Authors:
Porta, M
Ruiz, L
Jariod, M
Carrato, A
Malats, N
Citation: M. Porta et al., Authors' reply: Thinking about interactions and mechanisms, J EPIDEM C, 55(8), 2001, pp. 608-608
Authors:
Frixione, E
Lagunes, R
Ruiz, L
Urban, M
Porter, RM
Citation: E. Frixione et al., Actin cytoskeleton role in the structural response of epithelial (MDCK) cells to low extracellular Ca2+, J MUSCLE R, 22(3), 2001, pp. 229-242
Authors:
de la Vega, M
Rivero, JC
Ruiz, L
Suarez, S
Citation: M. De La Vega et al., A fish bone in the liver, LANCET, 358(9286), 2001, pp. 982-982
Authors:
Velasco, L
Ruiz, L
Sanchez, MG
Diaz-Laviada, I
Citation: L. Velasco et al., Delta(9)-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells - Involvement of CB1 cannabinoid receptor and Raf-1, EUR J BIOCH, 268(3), 2001, pp. 531-535
Authors:
Ruiz, L
Citation: L. Ruiz, Don[atien]-Belia[lphonse Francois]-de-Gehenna: Sade according to Potocki, EUR-REV LIT, 79(863), 2001, pp. 139-150
Authors:
Tuldra, A
Fumaz, CR
Ferrer, MJ
Bayes, R
Arno, A
Balague, M
Bonjoch, A
Jou, A
Negredo, E
Paredes, R
Ruiz, L
Romeu, J
Sirera, G
Tural, C
Burger, D
Clotet, B
Citation: A. Tuldra et al., Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy, J ACQ IMM D, 25(3), 2000, pp. 221-228
Authors:
Van Laethem, K
Schmit, JC
Pelemans, H
Balzarini, J
Witvrouw, M
Perez-Perez, MJ
Camarasa, MJ
Esnouf, RM
Aquaro, S
Cenci, A
Perno, CF
Hermans, P
Sprecher, S
Ruiz, L
Clotet, B
Van Wijngaerden, E
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Presence of 2 ',5 '-bis-O-(tert-butyldimethylsilyl)-3 '-spiro-5 ''-(4 ''-amino-1 '',2 ''-oxathiole-2 '',2 ''-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients, AIDS RES H, 16(9), 2000, pp. 825-833
Authors:
Van Vaerenbergh, K
Van Laethem, K
Van Wijngaerden, E
Schmit, JC
Schneider, F
Ruiz, L
Clotet, B
Verhofstede, C
Van Wanzeele, F
Muyldermans, G
Simons, P
Stuyver, L
Hermans, P
Evans, C
De Clercq, E
Desmyter, J
Vandamme, AM
Citation: K. Van Vaerenbergh et al., Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy, AIDS RES H, 16(6), 2000, pp. 529-537
Authors:
Textor, M
Ruiz, L
Hofer, R
Rossi, A
Feldman, K
Hahner, G
Spencer, ND
Citation: M. Textor et al., Structural chemistry of self-assembled monolayers of octadecylphosphoric acid on tantalum oxide surfaces, LANGMUIR, 16(7), 2000, pp. 3257-3271
Authors:
Puig, T
Perez-Olmeda, M
Rubio, A
Ruiz, L
Briones, C
Franco, JM
Gomez-Cano, M
Stuyver, L
Zamora, L
Alvarez, C
Leal, M
Clotet, B
Soriano, V
Citation: T. Puig et al., Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain, AIDS, 14(6), 2000, pp. 727-732
Authors:
Ruiz, L
Martinez-Picado, J
Romeu, J
Paredes, R
Zayat, MK
Marfil, S
Negredo, E
Sirera, G
Tural, C
Clotet, B
Citation: L. Ruiz et al., Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression, AIDS, 14(4), 2000, pp. 397-403
Authors:
Van Laethem, K
Witvrouw, M
Balzarini, J
Schmit, JC
Sprecher, S
Hermans, P
Leal, M
Harrer, T
Ruiz, L
Clotet, B
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir, AIDS, 14(4), 2000, pp. 469-471
Authors:
Casado, JL
Hertogs, K
Ruiz, L
Dronda, F
Van Cauwenberge, A
Arno, A
Garcia-Arata, I
Bloor, S
Bonjoch, A
Blazquez, J
Clotet, B
Larder, B
Citation: Jl. Casado et al., Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen, AIDS, 14(2), 2000, pp. F1-F7
Authors:
Porta, M
Malats, N
Alguacil, J
Ruiz, L
Jariod, M
Carrato, A
Rifa, L
Guarner, L
Citation: M. Porta et al., Coffee, pancreatic cancer, and K-ras mutations: updating the research agenda, J EPIDEM C, 54(9), 2000, pp. 656-659
Authors:
Van Vaerenbergh, K
Van Laethem, K
Albert, J
Boucher, CAB
Clotet, B
Floridia, M
Gerstoft, J
Hejdeman, B
Nielsen, C
Pannecouque, C
Perrin, L
Pirillo, MF
Ruiz, L
Schmit, JC
Schneider, F
Schoolmeester, A
Schuurman, R
Stellbrink, HJ
Stuyver, L
Van Lunzen, J
Van Remoortel, B
Van Wijngaerden, E
Vella, S
Witvrouw, M
Yerly, S
De Clercq, E
Desmyter, J
Vandamme, AM
Citation: K. Van Vaerenbergh et al., Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues, ANTIM AG CH, 44(8), 2000, pp. 2109-2117
Authors:
Balague, C
Zhou, JM
Dai, YF
Alemany, R
Josephs, SF
Andreason, G
Hariharan, M
Sethi, E
Prokopenko, E
Jan, HY
Lou, YC
Hubert-Leslie, D
Ruiz, L
Zhang, WW
Citation: C. Balague et al., Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector, BLOOD, 95(3), 2000, pp. 820-828
Authors:
Paredes, R
Puig, T
Arno, A
Negredo, E
Balague, M
Bonjoch, A
Jou, A
Tuldra, A
Tural, C
Sirera, G
Veny, A
Romeu, J
Ruiz, L
Clotet, B
Citation: R. Paredes et al., High-dose saquinavir plus ritonavir: Long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response, J ACQ IMM D, 22(2), 1999, pp. 132-138